Friday, March 25, 2022 8:08:39 AM
Recent TCBP News
- TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements • PR Newswire (US) • 10/30/2024 12:30:00 PM
- TCBP Responds to False Social Media Claim • PR Newswire (US) • 10/25/2024 01:45:00 PM
- Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research • AllPennyStocks.com • 10/22/2024 05:45:00 PM
- TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic • PR Newswire (US) • 10/22/2024 12:30:00 PM
- TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening • PR Newswire (US) • 10/03/2024 12:30:00 PM
- TCBP Announces Site Opening of Guys and St. Thomas Hospital • PR Newswire (US) • 09/25/2024 12:30:00 PM
- TCBP to Present at the 2024 ThinkEquity Conference in NYC • PR Newswire (US) • 09/24/2024 12:45:00 PM
- /C O R R E C T I O N -- TC BioPharm/ • PR Newswire (US) • 09/20/2024 08:00:00 PM
- TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial • PR Newswire (US) • 09/12/2024 12:30:00 PM
- TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox • PR Newswire (US) • 09/09/2024 12:30:00 PM
- TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox • PR Newswire (US) • 09/06/2024 08:00:00 PM
- TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference • PR Newswire (US) • 09/05/2024 12:30:00 PM
- TCBP Announces Dosing of 5 New Patients in ACHIEVE • PR Newswire (US) • 09/03/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/30/2024 07:52:09 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/29/2024 09:11:40 PM
- Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)] • Edgar (US Regulatory) • 08/28/2024 10:32:48 PM
- TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering • PR Newswire (US) • 08/28/2024 09:15:00 PM
- TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications • PR Newswire (US) • 08/28/2024 05:50:00 PM
- Form F-1/A - Registration statement for certain foreign private issuers: [Amend] • Edgar (US Regulatory) • 08/23/2024 09:30:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/23/2024 08:05:25 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 08/16/2024 08:20:27 PM
- TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b) • PR Newswire (US) • 08/15/2024 05:00:00 PM
- TC BioPharm Announces Closing of $2.0 Million Public Offering • PR Newswire (US) • 08/15/2024 03:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 02:47:52 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/14/2024 11:30:44 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM